Page last updated: 2024-10-22

amifostine anhydrous and Extrasystole, Ventricular

amifostine anhydrous has been researched along with Extrasystole, Ventricular in 1 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Research Excerpts

ExcerptRelevanceReference
"Aminothiol amifostine (AMI) protects against toxic effects of both ionizing radiation and numerous anticancer drugs."1.32Amifostine protection against doxorubicin cardiotoxicity in rats. ( Bokonjic, DR; Dobric, SL; Dogovic, NP; Dragojevic-Simic, VM; Jacevic, VM; Sinovec, SM; Vucinic, ZM, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dragojevic-Simic, VM1
Dobric, SL1
Bokonjic, DR1
Vucinic, ZM1
Sinovec, SM1
Jacevic, VM1
Dogovic, NP1

Other Studies

1 other study available for amifostine anhydrous and Extrasystole, Ventricular

ArticleYear
Amifostine protection against doxorubicin cardiotoxicity in rats.
    Anti-cancer drugs, 2004, Volume: 15, Issue:2

    Topics: Aconitine; Amifostine; Animals; Ascitic Fluid; Body Weight; Cardiac Tamponade; Cardiomyopathies; Dox

2004